The risk with any pharma company is that the product fails during R&D. Having this many products significantly mitigates against that risk.
Bought: 4d Pharma

Notes on a small investment portfolio
The risk with any pharma company is that the product fails during R&D. Having this many products significantly mitigates against that risk.
I can foresee the share price falling further in the short term. I may open a position again when Nuvec is further along in development.
Given the increasing demand for green-energy, there are surely government contracts to be won. Simec Atlantis seems well placed to win these.
Demand for green-tech is rising and Eqtec offers an ‘Advanced Gasification Technology’ to generate safe, green energy from different varieties of waste.
Given the need of vaccines to help defeat Covid, there will surely be a high demand for a product that increases their efficacy.
I currently don’t own any mining companies. Bushveld seems like a good place to start, and gains me exposure to Vanadium.
TILS looks to be an exciting company with multiple projects in the pipeline. I also like the look of the Covid product they are developing.
I’m very keen on owning shares in Tesla, and SMT is overweight in this fast growing stock.
I bought this at 69.5p, after asking for advice on a fast growing stock which might benefit from the COVID-19 crisis.